| Ticker Symbol: | UTHR |
|---|---|
| Exchange: | NASD |
| Contact Info: | 1110 Spring Street Silver Spring MD 20910 301 608-9292 |
| CEO/President: | Paul A. Mahon J.D. |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services. |
| Shares Outstanding: | 22,810 (000) | Market Value: | 1,219,520 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 96.08% | Number of Inst.Shareholders: | 10.90% |
| Last Quarter Sales: | 75.03 ($Mil.) | Last Quarter Net Income: | 12.62 ($Mil.) |
| Last Quarter EPS: | 0.50 | P/E Ratio: | 32 |
| Most Recent Earnings: | 0.50 on 10/30/08 | Earnings Per Share: | 1.64 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| PFIZER INC | -30.10 | 16.02 | |
| JOHNSON AND JOH | -17.70 | 56.83 | |
| BRISTOL MYERS S | -22.70 | 20.28 | |
| SCHERING PLOUGH | -39.70 | 16.13 | |
| MERCK CO INC | -54.40 | 26.68 |
